BRISBANE, Australia, March 28, 2025 /PRNewswire/ — Cryptsoft’s KMIP and PKCS#11 SDKs now include support for interoperable post-quantum cryptography (PQC) algorithms. Cryptsoft’s new PQC-enabled SDKs are an enhancement to its existing market-leading SDKs and include verified and…
Month: March 2025
Support Latest Post-Quantum-Cryptography algorithms with Cryptsoft’s SDKs
BRISBANE, Australia, March 28, 2025 /PRNewswire/ — Cryptsoft’s KMIP and PKCS#11 SDKs now include support for interoperable post-quantum cryptography (PQC) algorithms. Cryptsoft’s new PQC-enabled SDKs are an enhancement to its existing market-leading SDKs and include verified and…
IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau
SHANGHAI, NANJING, China and SAN JOSE, Calif., March 28, 2025 /PRNewswire/ — IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that the…
IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau
SHANGHAI, NANJING, China and SAN JOSE, Calif., March 28, 2025 /PRNewswire/ — IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that the…
IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau
SHANGHAI, NANJING, China and SAN JOSE, Calif., March 28, 2025 /PRNewswire/ — IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that the…
IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau
SHANGHAI, NANJING, China and SAN JOSE, Calif., March 28, 2025 /PRNewswire/ — IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that the…
Keystone Dental Appoints Tony Susino as Chief Executive Officer & Board Member
IRVINE, Calif., March 28, 2025 /PRNewswire/ — Keystone Dental Holdings, Inc. announced the appointment of Tony Susino as Chief Executive Officer and member of its Board of Directors, effective immediately. “Tony brings a proven track record of clear strategic vision, commercial success,…
DMEGC publica su Informe Anual 2024: Ingresos de 2.400 millones de euros y leve subida de los beneficios
JINHUA, China, 28 de marzo de 2025 /PRNewswire/ — DMEGC dio a conocer el 11 de marzo su informe anual de 2024, que revela que la empresa alcanzó unos ingresos anuales de 2.400 millones de euros, con un beneficio neto atribuible a la sociedad matriz de 238 millones de euros, lo que supone…
Fangzhou Inc. Named Among Guangzhou’s Top AI Innovators for Intelligent Healthcare Platform
GUANGZHOU, China, March 27, 2025 /PRNewswire/ — Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in Internet healthcare solutions, has been named to the 2024 Guangzhou Artificial Intelligence Innovation Development List as “Most Promising Enterprise,” while its H2H Smart…
2025 ZGC International Technology Trade Fair Opens in Beijing
BEIJING, March 28, 2025 /PRNewswire/ — The Opening Ceremony and Global Technology Commercialization Eco-Partnership Conference of 2025 ZGC International Technology Trade Fair kicked off in Zhongguancun Exhibition and Transfer Center on the afternoon of March 27. Themed “New Quality…
